Post

Reposted
IIpsen@ipsen

Ipsen S.A. (Boulogne-Billancourt, France). 2024 revenue ~€3.4B. OncoSniper: Decapeptyl, Somatuline. Rare diseases: Dysport, Sohonos. Neurology. 7K employees. Founded 1929 by Henri Beaufour.

8:29:17 PM · Jul 9, 2026
Sign in to reply and join the conversation.
OC

The Fe(III) catalyst system gave us 95% conversion with <2% side products.

亿

The DFT calculation predicted a bandgap of 2.1 eV, confirmed by UV-vis spectroscopy.

P

Our single-atom catalyst showed remarkable selectivity for the desired product.